Top

Published in:

01-06-2021 | Central Nervous System Trauma | Practical Pearl

Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST)

Authors: Niall A. Buckley, Mustafa K. Baskaya, Marin E. Darsie

Published in: Neurocritical Care | Issue 3/2021

Excerpt

There is an absence of literature discussing heparin-induced thrombocytopenia (HIT) management in traumatic brain injury (TBI) patients with post-traumatic cerebral venous sinus thrombosis (CVST). …

Nguyen R, Fiest K, McChesney J, et al. The international incidence of traumatic brain injury: a systematic review and meta-analysis. Can J Neurol Sci. 2016;43(6):774–85.CrossRef

Dewan M, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2019;130(4):1080–97.CrossRef

Delgado Almandoz J, Kelly H, Schaefer P, Lev M, Gonzalez R, Romero J. Prevalence of traumatic dural venous sinus thrombosis in high-risk acute blunt head trauma patients evaluated with multidetector CT venography. Radiology. 2010;255(2):570–7.CrossRef

Filippidis A, Kapsalaki E, Patramani G, Fountas K. Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus. 2009;27(5):E3.CrossRef

Saposnik G, Barinagarrementeria F, Brown R, et al. Diagnosis and management of cerebral venous thrombosis. Stroke. 2011;42(4):1158–92.CrossRef

Smythe M, Koerber J, Mattson J. The incidence of recognized heparin-induced thrombocytopenia in a large. Tert Care Teach Hosp Chest. 2007;131(6):1644–9.

Arepally G, Ortel T. Heparin-induced thrombocytopenia. Annu Rev Med. 2010;61(1):77–90.CrossRef

Martel N, Lee J, Wells P. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005;106(8):2710–5.CrossRef

Kim J, Gearhart M, Zurick A, Zuccarello M, James L, Luchette F. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma Inj Infect Crit Care. 2002;53(1):38–433.CrossRef

10.

Ning S, Warkentin T. IV immunoglobulin for autoimmune heparin-induced thrombocytopenia. Chest. 2017;152(3):453–5.CrossRef

11.

Park B, Kumar M, Nagalla S, et al. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia. Transfus Apheres Sci. 2018;57(4):561–5.CrossRef

12.

Mohanty E, Nazir S, Sheppard J, Forman D, Warkentin T. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome. J Thromb Haemost. 2019;17(5):841–4.CrossRef

13.

Irani M, Siegal E, Jella A, Aster R, Padmanabhan A. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia. Transfusion. 2018;59(3):931–4.CrossRef

14.

Ammann EM, Haskins CB, Fillman KM, et al. Intravenous immune globulin and thromboembolic adverse events: a systematic review and meta-analysis of RCTs. Am J Hematol. 2016;91(6):594–605.CrossRef

15.

Thomas S, Makris M. The reversal of anticoagulation in clinical practice. Clin Med. 2018;18(4):314–9.CrossRef

16.

Warkentin T, Crowther M. Reversing anticoagulants both old and new. Can J Anaesth. 2002;49:S11–S25.PubMed

17.

Lee C, Ansell J. Direct thrombin inhibitors. Br J Clin Pharmacol. 2011;72(4):581–92.CrossRef

18.

Joppa S, Salciccioli J, Adamski J, et al. A practical review of the emerging direct anticoagulants, laboratory monitoring, and reversal agents. J Clin Med. 2018;7(2):29.CrossRef

Title: Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST)
Authors: Niall A. Buckley
Mustafa K. Baskaya
Marin E. Darsie
Publication date: 01-06-2021
Publisher: Springer US
Keywords: Central Nervous System Trauma
Cerebral Sinus Venous Thrombosis
Epidural Hematoma
Thrombocytopenia
Heparin
Low Molecular Weight Heparin
Heparin-Induced Thrombocytopenia
Tracheostomy
Fondaparinux
Intracranial Hypertension
Published in: Neurocritical Care / Issue 3/2021
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-020-01101-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST)

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2021

Liver Fibrosis and Perihematomal Edema Growth in Primary Intracerebral Hemorrhage

Prevalence, Predictors, and Outcomes of Prolonged Mechanical Ventilation After Endovascular Stroke Therapy

Looking Twice the Wrong Way: The Challenge of Diagnosing Acute Basilar Artery Occlusion

Monitoring the Burden of Seizures and Highly Epileptiform Patterns in Critical Care with a Novel Machine Learning Method

To Decompress or Not? An Expected Utility Inspired Approach To Shared decision-making For Supratentorial Ischemic Stroke

Intensive Care Unit—Acquired Weakness in Children: A Prospective Observational Study Using Simplified Serial Electrophysiological Testing (PEDCIMP Study)